Condition-Specific Wellness
Neridronate Enters Phase 3 Trial for Rare Pain Condition CRPS-1
With an estimated 65,000 new U.S. cases annually, CRPS-1 represents a significant unmet need that could open upstream i…
With an estimated 65,000 new U.S. cases annually, CRPS-1 represents a significant unmet need that could open upstream i…